KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Equity (2018 - 2025)

Historic Return on Equity for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to 1.8%.

  • Aquestive Therapeutics' Return on Equity rose 9300.0% to 1.8% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.8%, marking a year-over-year increase of 9300.0%. This contributed to the annual value of 0.53% for FY2024, which is 4600.0% up from last year.
  • As of Q3 2025, Aquestive Therapeutics' Return on Equity stood at 1.8%, which was up 9300.0% from 0.97% recorded in Q2 2025.
  • Aquestive Therapeutics' Return on Equity's 5-year high stood at 1.8% during Q3 2025, with a 5-year trough of 0.08% in Q4 2023.
  • For the 5-year period, Aquestive Therapeutics' Return on Equity averaged around 0.75%, with its median value being 0.79% (2022).
  • In the last 5 years, Aquestive Therapeutics' Return on Equity plummeted by -39700bps in 2021 and then surged by 9300bps in 2025.
  • Aquestive Therapeutics' Return on Equity (Quarter) stood at 0.99% in 2021, then tumbled by -51bps to 0.48% in 2022, then tumbled by -84bps to 0.08% in 2023, then soared by 1012bps to 0.84% in 2024, then skyrocketed by 115bps to 1.8% in 2025.
  • Its Return on Equity stands at 1.8% for Q3 2025, versus 0.97% for Q2 2025 and 0.9% for Q1 2025.